mercredi 25 novembre 2015

Onco Actu du 25 novembre 2015

2.6 Etiologie - Environnement

Diesel emissions – an emerging public health issue? [Cancer Research UK]

3. Prévention

Jane Wardle obituary [The Guardian]

3.1 Tabac

For teens and tobacco, out of sight might mean out of mind [Reuters]

5.2.1 Pharma - Partenariats

Bristol-Myers Squibb in new oncology collaboration [Pharmafile]

5.3 Traitements - FDA, EMA,...

European Commission Approves Reconciliation of Indications for nivolumab Under the Opdivo® European Marketing Authorization Application [BMS]

Merck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products [Pfizer]

5.3.4 Traitements - AMM (FDA, EMA)

Pfizer Receives European Approval to Expand Use of XALKORI® (crizotinib) to First-Line Treatment of Adults with ALK-Positive Advanced Non-Small Cell Lung Cancer [Pfizer]

Lilly's middling lung cancer drug wins FDA approval with a restrictive label [FierceBiotech]

FDA Approves Portrazza™ (necitumumab) for Specific Type of Lung Cancer [Lilly]

FDA approves Portrazza to treat advanced squamous non-small cell lung cancer [FDA]

FDA approves expanded use of Bristol-Myers' skin cancer drug [Reuters]

FDA approves Lilly's lung cancer drug [Reuters]

5.4 Traitements - Economie

NICE consults on ovarian cancer treatments draft guidance [NICE]

Why Many Cancer Drugs Don't Have To Cost So Much [Forbes]

6. Lutte contre les cancers

ASTRO launches template to help radiation oncologists guide cancer survivors through ongoing care [ASTRO]

6.1 Observation

Eight-year-old Utah girl diagnosed with rare form of breast cancer [The Guardian]

6.9 Controverses

Brazilian courts tussle over unproven cancer treatment [Nature News & Comment]